BACKGROUND: Chronic venous disease (CVD)is major health concern; however,there remains a need to improve treatment approaches.Nédemax Mese , a nutritional supplementation consisting of Leucoselect 300 mg,Lymphaselect 100 mg and Bromelain 100 mg, is a patented formulation thah may have a role in the treatment of CVD. In this prospective , multicenter study conducted at 54 Italian centers, we investigated the effectiveness of Nédemax Mese in a large sample of CVD patients.
Nédemax mese (Leucoselect, Lymphaselect, Bromelain) in the treatment of chronic venous disease: a multicenter , obbservational study / Albrigo, Rino; Andreoni, Cinzia; Anello, Gaetano; Barboni, Maria G.; Barzaghi, Elena; Bianchi, Daniele; Camassa, Nino; Carissimi, Tiziana; Collarino, Francesco; Cozzolino, Giuseppe; Cravero, Enzo; Cristiani, Alfonso; Del Corso, Andrea; Dibiase, Massimiliano; Di Cosmo, Incoronata; Ermirio, Domenico; Farina, Massimiliano; Florio, Anna; Fornalè, Lorenzo; Franchini, Gianluigi; Franzoso, Massimo; Ferri, Monica; Gallinacci, Elena; Gazzetti, Marianna; Giacomelli, Elena; Giuliani, Nadia; Grimaldi, Giuseppe; Guida, Carmela; Iurlaro, Vincenzo; Marcellino, Maria G.; Mele, Rita; Mercadalli, Giulio; Mirabella, Domenico; Mondani, Paolo; Morozzo, Giorgio; Noce, Luigino; Oberto, Sara; Paccassi, Stefania; Pagano, Guerino; Pagliasso, Elisa; Palazzo, Annunziata; Palombi, Maurizio; Paolo Palumbo, Francesco; Petracca, Giovanni; Pontello, Daniele; Puviani, Lorenza; Puzzo, Alfonso; Ragni, Elena; Simoncini, Fabio; Somigli, Lorenzo; Spina, Tommaso; Spinamano, Luca; Terreni, Angela; Tondo, Salvatore; Tonelli, Vincenzo; Tortora, Andrea; Giacomelli, Luca. - In: ACTA PHLEBOLOGICA. - ISSN 1593-232X. - 20:1(2019), pp. 8-14. [10.23736/S1593-232X.1900437-5]
Nédemax mese (Leucoselect, Lymphaselect, Bromelain) in the treatment of chronic venous disease: a multicenter , obbservational study
Rita Mele;
2019
Abstract
BACKGROUND: Chronic venous disease (CVD)is major health concern; however,there remains a need to improve treatment approaches.Nédemax Mese , a nutritional supplementation consisting of Leucoselect 300 mg,Lymphaselect 100 mg and Bromelain 100 mg, is a patented formulation thah may have a role in the treatment of CVD. In this prospective , multicenter study conducted at 54 Italian centers, we investigated the effectiveness of Nédemax Mese in a large sample of CVD patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
Albrigo_NÉDEMAX -MESE_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
2.65 MB
Formato
Adobe PDF
|
2.65 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
